Imrestor

RSS

Pegbovigrastim

Authorised
This medicine is authorised for use in the European Union.

Overview

This is a summary of the European public assessment report (EPAR) for Imrestor. It explains how the Agency assessed this veterinary medicine to recommend its authorisation in the European Union (EU) and its conditions of use. It is not intended to provide practical advice on how to use Imrestor.

For practical information about using Imrestor, animal owners or keepers should read the package leaflet or contact their veterinarian or pharmacist.

This EPAR was last updated on 20/12/2018

Authorisation details

Product details
Name
Imrestor
Agency product number
EMEA/V/C/002763
Active substance
Pegbovigrastim
International non-proprietary name (INN) or common name
Pegbovigrastim
Species
  • Cattle (cows and heifers)
  • Cattle
Anatomical therapeutic chemical veterinary (ATCvet) codes
QL03AA90
Publication details
Marketing-authorisation holder
Elanco GmbH
Revision
1
Date of issue of marketing authorisation valid throughout the European Union
09/12/2015
Contact address

Heinz-Lohmann-Str. 4
27472 Cuxhaven
Germany

Product information

07/12/2018 Imrestor - EMEA/V/C/002763 - T/0008

Contents

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

Antineoplastic and immunomodulating agents immunostimulants immunostimulants colony stimulating factors pegbovigrastim

Therapeutic indication

As an aid in a herd management programme, to reduce the risk of clinical mastitis in periparturient dairy cows and heifers during the 30 days following calving.

Assessment history

How useful was this page?

Add your rating